Introduction {#Sec1}
============

In patients with congestive heart failure, pacemaker leads for cardiac resynchronization therapy (CRT) are placed in one of the tributaries of the coronary sinus (CS) system, located in the lateral wall of the left ventricle \[[@CR1]\]. Because the cardiac veins are variable in number, caliber, and course, pre-implantation knowledge of the venous anatomy may help cardiologists to decide whether intravenous implementation should be performed and choose the optimal placement of the left ventricular lead implantation. Thus, there is a clinical need for imaging the cardiac venous system.

There are only a few methods of imaging the cardiac venous system. Retrograde cardiac venography via the CS is the current gold standard for defining the cardiac venous anatomy. However, such a procedure is invasive, technically challenging, and unable to outline the cardiac arteriovenous relationship. Ideally, venous anatomy should be assessed before implantation noninvasively in the outpatient clinic to determine whether a transvenous approach is feasible. Therefore, efforts have been made over recent years to explore new methods of imaging. For example, multislice spiral computed tomography (MSCT) has become an important tool for noninvasive visualization of the cardiac venous system \[[@CR2]--[@CR5]\]. Recent studies using whole-heart steady-state free precession (SSFP) coronary MRA (CMRA) demonstrates that MR can visualize the anatomy of the cardiac venous system at 1.5T \[[@CR6]--[@CR10]\].

Contrast-enhanced whole-heart CMRA has been used to evaluate the coronary arteries at 3.0T \[[@CR11]--[@CR13]\]. However, no data are currently available on the use of this 3.0T whole-heart CMRA technique to visualize the cardiac venous anatomy. The purpose of the work was to evaluate the value of contrast-enhanced whole-heart CMRA at 3.0T in depicting the cardiac venous anatomy: the CS and its tributaries.

Materials and Methods {#Sec2}
=====================

Study population {#Sec3}
----------------

The anatomy of the cardiac veins was retrospectively studied in 51 consecutive subjects (45 patients with suspected coronary artery disease and 6 healthy volunteers; 26 men; age 59 ± 11 years) in whom 3.0T contrast-enhanced whole-heart CMRA was performed for non-invasive evaluation of the coronary arteries. The study was approved by the institutional review board and informed consents were obtained from each subject.

Contrast-enhanced whole-heart CMRA {#Sec4}
----------------------------------

The CMRA was performed on a 3.0T whole-body clinical scanner (MAGNETOM Tim Trio, Siemens Healthcare, Erlangen, Germany) equipped with a 32-element cardiac coil.

All images of coronary vessels were acquired during free-breathing with the subjects in a supine position. A navigator-gated, electrocardiography-triggered, fat saturated, segmented 3D fast low-angle shot (FLASH) sequence was utilized for CMRA \[[@CR11]\]. Navigator pulses localized at the dome of the right hemidiaphragm with a 5-mm acceptance window was used for respiratory gating. The 3D k-space data were collected with a centric ordering scheme in the phase-encoding direction and a linear ordering scheme in the partition-encoding direction. A nonselective inversion pulse (TI = 200 ms) was applied prior to the navigator-echo pulses to suppress the background signal. Sixty-four to 72 slices were acquired and interpolated to 128--144 slices of 0.65 mm thick. To reduce the image acquisition time, parallel data acquisition was used in the phase-encoding direction with an acceleration factor of 3. Prior to coronary MRA, a cine scan was performed to identify cardiac phase with minimal motion of the right coronary artery (RCA) \[[@CR11]--[@CR13]\]. The data acquisition window and the number of k-space lines acquired per heartbeat were set accordingly to synchronize data acquisition to minimal motion phases, either during systole or diastole. Other imaging parameters were as follows: TR = 3.56 ms, TE = 1.61 ms, flip angle = 20°, number of lines per heartbeat = 30--50, readout bandwidth = 709 Hz/pixel, and voxel size = 1.1 × 1.1 × 1.3 mm^3^ interpolated to 0.55 × 0.55 × 0.65 mm^3^.

0.15 mmol/kg body weight of MultiHance (Bracco Imaging SpA, Milan, Italy) was slowly injected using a power injector (Spectris, Medrad, Indianola, PA, USA) at a rate of 0.3 ml/s, immediately followed by 20 ml of saline injected at the same rate. Imaging acquisition started 80 s after the initialization of contrast agent administration \[[@CR11]--[@CR13]\].

Data analysis {#Sec5}
-------------

Data reformation and analysis were performed on a commercially available workstation (Leonardo, Siemens Healthcare, Erlangen, Germany).

### Anatomic observation {#Sec6}

The tributaries of the cardiac veins were identified on volume-rendered reconstructions. Thereafter, the course of the veins was evaluated in 3 orthogonal planes using multiplanar reformatting. The presence of the following cardiac veins was evaluated: CS, posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV), left marginal vein (LMV), and anterior interventricular vein (AIV) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Volume-rendered image provides an overview of cardiac venous anatomy and clearly depicts the coronary sinus (CS), posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV), left marginal vein (LMV), and anterior interventricular vein (AIV)

### Quantitative data {#Sec7}

The ostium of the CS was defined as the site where the CS makes an angle with the right atrium (RA) in the crux cordis area \[[@CR4], [@CR5], [@CR9]\]. Multiplanar reformatting was used to determine the size of the ostium of the CS in anteroposterior and superoinferior direction (Fig. [2](#Fig2){ref-type="fig"}) and to measure the starting diameter of each identified tributary. The length of the tributaries, the distance from the ostium to tributaries and the angle between the tributaries and CS or great cardiac vein were measured on volume-rendered reconstructions (Fig. [3](#Fig3){ref-type="fig"}). The angle of the CS ostium was measured in the axial images \[[@CR14]\]. The visibility of the cardiac veins was graded visually using a 4-point scale by assessing raw images (1: poor, 2: moderate, 3: good, and 4: excellent) \[[@CR13], [@CR15]\].Fig. 2**a** The CS ostium measured in the anteroposterior direction; transverse plane; **b** The CS ostium in superoinferior direction; coronary planeFig. 3Example of measurement of the angle between the tributaries and CS or great cardiac vein and of the distance from the ostium to tributaries

Statistical analysis {#Sec8}
--------------------

A statistical software program, SPSS 13.0 (SPSS Inc., Chicago, IL, USA), was used for statistical analysis. Continuous variables were expressed as mean ± standard deviation. Categorical variables were expressed as absolute number (percentage). The paired Student *t* test was used to evaluate differences in diameters of the ostium of the CS in anteroposterior and superoinferior direction. Statistical tests were 2-tailed, and a *P* value \< 0.05 was considered to be significant.

Results {#Sec9}
=======

Acquisition time of whole-heart CMRA procedure was 7.1 ± 2.2 min. The CMRA was acquired during diastole in 43 subjects (acquisition window 139 ± 41 ms) and during systole in 8 subjects (acquisition window 91 ± 9 ms). The average navigator efficiency was 36%.

The cardiac veins were finally evaluated in 48 of 51 subjects. Data from 3 subjects were excluded for analysis due to non-assessable image quality caused by poor contrast-to-noise ratio (CNR) (n = 2) and motion artifacts (n = 1).

Anatomic observation {#Sec10}
--------------------

The CS and PIV were observed in 48/48 (100%) subjects. The PVLV was visualized in 42/48 subjects (88%), the LMV in 33/48 (69%), and the AIV in 38/48 (79%).

Anatomic variation {#Sec11}
------------------

Two subjects showed common origin of PIV and PVLV from CS (Fig. [4](#Fig4){ref-type="fig"}a). In 1 subject, the small cardiac vein (SCV) connected to the PIV and the PIV connected to the CS at the crux cordis (Fig. [4](#Fig4){ref-type="fig"}b). This kind of anatomic variation was not included in Jongbloed's classification of variable anatomy (In Jongbloed's Variant 1: Continuity of the cardiac veins at the crux cordis. The SCV connects to the CS at the crux cordis) \[[@CR4]\].Fig. 4**a** Volume-rendered image shows common origin of PIV and PVLV from the CS. **b** A new found anatomic variation: the small cardiac vein (SCV) connected to the PIV and the PIV connected to the CS at the crux cordis

Quantitative data {#Sec12}
-----------------

Table [1](#Tab1){ref-type="table"} lists the quantitative data of the PIV, PVLV, LMV, and AIV. The diameter of the CS ostium in the superoinferior direction (1.13 ± 0.26 cm) was larger than in the anteroposterior direction (0.82 ± 0.19 cm) (*P* \< 0.05). The angle of the CS ostium was 59° ± 7°. The visibility is displayed in Table [2](#Tab2){ref-type="table"}.Table 1Quantitative measurement of cardiac veins from 48 subjectsOstial diameter (cm)Length (cm)Distance from the ostium of CS (cm)Angle between the identified veins and CS or great cardiac veinPIV (n = 48)0.4 ± 0.13.1 ± 1.80.6 ± 0.481° ± 19°PVLV (n = 42)0.3 ± 0.12.8 ± 2.53.0 ± 1.0108° ± 26°LMV (n = 33)0.2 ± 0.12.1 ± 2.06.5 ± 1.1119° ± 30°AIV (n = 38)0.3 ± 0.14.5 ± 1.69.9 ± 1.5132° ± 17°Data are means ± standard deviations*AIV* anterior interventricular vein, *CS* coronary sinus, *LMV* left marginal vein, *PIV* posterior interventricular vein, *PVLV* posterior vein of the left ventricleTable 2Distribution of visibility grades of the cardiac veinsVisibility grade n (%)1234MeanCS0 (0)0 (0)0 (0)48 (100)4.0 ± 0.0PIV0 (0)0 (0)27 (56)21 (44)3.4 ± 0.5PVLV0 (0)0 (0)26 (62)16 (38)3.4 ± 0.5LMV2 (6)5 (15)18 (55)8 (24)3.0 ± 0.8AIV0 (0)0 (0)27 (71)11 (29)3.3 ± 0.5Data are n (%) or means ± standard deviations. The visibility grade of the cardiac veins: 1 = poor; 2 = moderate; 3 = good; 4 = excellent*AIV* anterior interventricular vein, *CS* coronary sinus, *LMV* left marginal vein, *PIV* posterior interventricular vein, *PVLV* posterior vein of the left ventricle

Discussion {#Sec13}
==========

This work shows that contrast-enhanced whole-heart CMRA at 3.0T can depict the normal and variant cardiac venous anatomy. Previous studies using navigator-gated, whole-heart SSFP CMRA demonstrate that MR can visualize the anatomy of the cardiac venous system at 1.5T \[[@CR6]--[@CR10]\]. 3.0T systems have higher signal-to-noise ratio (SNR) and CNR than 1.5T \[[@CR16]--[@CR19]\]. Nevertheless, the SSFP imaging technique that has gained wide acceptance at 1.5T is prone to imaging artifacts at 3.0T because of the increased magnetic field inhomogeneity and radiofrequency (RF) distortion at higher field strengths. Compared to SSFP, spoiled gradient-echo imaging (e.g., FLASH) is less sensitive to static and RF field inhomogeneities, and results in more consistent image quality among subjects at 3.0T. The 3.0T imaging and contrast-enhancement combined with inversion-recovery preparation allow high contrast between blood and background tissue. The image quality of cardiac veins can be improved as a result.

Currently, one of the major challenges for whole-heart CMRA is the long scan time and image artifacts caused by motion instability during the long scan time. Previous contrast-enhanced CMRA study at 3.0T using 12-channel coils \[[@CR13]\] had reported reduced acquisition time compared to conventional SSFP CMRA at 1.5 T \[[@CR15]\] (9 min vs. 13 min). Using higher parallel imaging factor, the acquisition time is shortened to 7.1 ± 2.2 min in this study. Sufficient SNR and image quality were maintained by imaging at 3.0T and utilization of 32-channel phased-array coils \[[@CR20]--[@CR22]\]. The shorter scan time has potential to improve spatial resolution and reduce image artifacts caused by increased motion instability during the long scan time \[[@CR13], [@CR15]\].

The results of our study confirm a substantial variation in the cardiac venous anatomy. First, the CS was analyzed. The finding that the CS ostium is ovally shaped agrees with observations in other cardiac veins \[[@CR4], [@CR5], [@CR9]\]. Second, the tributaries of the CS were evaluated. Meisel et al. \[[@CR23]\] studied 129 patients referred for cardioverter-defibrillator implantation with invasive venography and noted a PVLV in 55% and a LMV in 83%. In studies using 16-slice or 64-slice MSCT, the prevalence of the PIV varied between 99 and 100%, the prevalence of the PVLV between 82 and 96%, and the prevalence of the LMV between 27 and 71% \[[@CR4], [@CR5]\]. Chiribiri et al. \[[@CR9]\] retrospectively evaluated the feasibility of contrast-enhanced SSFP CMRA at 1.5T to depict the anatomy of the cardiac venous system in 23 subjects and found the CS in 100% of subjects, the PIV in 96%, the PVLV in 78%, the LMV in 70%, and the AIV in 65%. In our study using contrast-enhanced whole-heart CMRA at 3.0T in 48 subjects, the CS and PIV were observed in 100% of subjects, the PVLV in 88%, the LMV in 69%, and the AIV in 79%.

Compared with other techniques for imaging the cardiac venous system, CMRA is noninvasive and does not require injection of iodinated contrast medium or expose patients to ionizing radiation. Thus, CMRA offers a relatively safe tool for the evaluation of the cardiac venous anatomy.

There were several limitations to this study. First, the CMRA used in this study was designed to provide optimal visualization of the coronary arteries, and may therefore be suboptimal for demonstration of the cardiac veins. Further studies will be required to define the best methodology to depict the cardiac venous anatomy by CMRA. Second, like previous 1.5T MR cardiac vein imaging studies \[[@CR6]--[@CR10]\], we did not compare our 3.0T whole-heart CMRA technique with the current invasive gold standard, retrograde cardiac venography. This issue is relevant because it is unknown whether cardiac vein branches not visualized were not present because of venous anatomic variation or present but not visualized. Third, the efficacy of CMRA for cardiac venous assessment specifically in patients with congestive heart failure has not yet been assessed and may prove more challenging. Finally, use of contrast media results in additional study cost as well as potential side effects. Additional precautions are necessary to rule out patients with poor renal function. It is also difficult to repeat the scan in the same imaging session if the acquisition is aborted or image quality is suboptimal \[[@CR13]\]. Utilization of intravascular contrast agent may allow for a longer time window for contrast-enhanced imaging, as well as repeat of measurement if necessary.

In conclusion, contrast-enhanced whole-heart CMRA at 3.0T can depict the normal and variant cardiac venous anatomy. Pre-implantation knowledge of the venous anatomy may help determine whether transvenous left ventricular lead placement for CRT is feasible.
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